Mebutamate (Capla, Dormate) is discontinued (DEA controlled substance). It is an anxiolytic and sedative drug with antihypertensive effects of the carbamate class. It has effects comparable to those of barbiturates such as secobarbital, but is only around 1/3 the potency of secobarbital as a sedative. Side effects include dizziness and headaches. References: Segelman FH, Kelton E, Terzi RM, Kucharczyk N, Sofia RD. The comparative potency of phenobarbital and five 1,3-propanediol dicarbamates for hepatic cytochrome P450 induction in rats. Res Commun Chem Pathol Pharmacol. 1985 Jun;48(3):467-70. PubMed PMID: 4023427.

纯度：≥98%

CAS：64-55-1